In an age of fast-paced content, younger generations have found serenity discovering classical music in the digital age via the popularity it has gained on TikTok. Generation Z has been posting TikTok ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Compiled by the Official Charts Company, the UK's biggest specialist classical albums of the week, based on sales of digital bundles, CDs, vinyl and other formats, across a seven day period.

Novo's new obesity therapy Wegovy is significantly expanding the obesity treatment market given its strong efficacy and is poised to remain a key drug in the market until patent expiration in 2032.

Novo Nordisk A/S is launching its top-selling Wegovy obesity drug in China at a fraction of the US price, a key step in unlocking a big, fast-growing market for its blockbuster franchise.

Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely ...

Novo Nordisk NOVO.B-1.53%decrease; red down pointing triangle has launched its blockbuster Wegovy weight-loss drug in China, adding the world’s second-largest economy to its growing list of ...

The bursting schedules of concerts at the Wigmore Hall, the Barbican Centre and South Bank Centre, and the strength of music in Birmingham, Manchester, Leeds and Cardiff, among other cities, show a ...

There has never been a generation in China as privileged as Generation Z. Born between 1995 and 2009, the Chinese Zoomers have lived most of their lives during the country's astounding economic ...